Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...
4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...
Global Market" has been added to ResearchAndMarkets.com's offering.The global fusion proteins market is poised to expand ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...
Federal enforcement of the False Claims Act (FCA) against healthcare and pharmaceutical companies—especially based on alleged Anti-Kickback Statute (AKS) violations—continues to change, with the ...
Investor's Business Daily on MSN
Stock Market Powers Higher Amid Huge Earnings, Federal Reserve, Trump-Xi: Weekly Review
The stock market had strong weekly gains after huge earnings, the latest Federal Reserve move and a Trump-Xi meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback